Study suggests new approach to improve radiation therapy resistance in glioblastoma
Many modern cancer drugs target a specific genetic mutation that is driving a particular cancer's runaway growth and division—such as the HER-2 protein in some breast cancers or EGFR in certain lung cancers.
Jul 30, 2020
0
91